Foundayo

Lilly's Oral Pivot: Foundayo's Maintenance Data Isn't a Scientific Win — It's a Market Access Weapon

Article: Opinion

Lilly’s Oral Pivot: Foundayo’s Maintenance Data Isn’t a Scientific Win — It’s a Market Access Weapon

Lilly's ATTAIN-MAINTAIN trial shows Foundayo maintains weight loss after injectable GLP-1s — a $42B market's access problem just found...

By Moe Alsumidaie
May 13, 2026

Read More